The following is a summary of “Steroid-resistant nephrotic syndrome due to renal-limited thrombotic microangiopathy and ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Jessica Matthews raises awareness of deadly cancer outcomes for Black people while sharing intimate moments, losing her hair ...

Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney ...

Renal medullary carcinoma (RMC) is a highly aggressive malignancy defined by the loss of the SMARCB1 tumor suppressor. It mainly affects young individuals of African descent with sickle cell trait, ...

Is thyroid cancer hereditary? Thyroid cancer can be hereditary or acquired. Associated familial diseases have their own inheritance pattern, and some have known gene defects. They include familial ...

More thyroid cancers were detected soon after starting a GLP-1 receptor agonist than other diabetes drugs, a secondary analysis of a target trial emulation of a comparative effectiveness study found.

After evaluation at an urgent care and four evaluations in the emergency department, the patient was admitted and ultimately diagnosed with metastatic medullary renal cell carcinoma. This case ...

advanced medullary thyroid carcinoma, metastatic colorectal cancer, advanced renal cell carcinoma, esophageal squamous cell carcinoma, recurrent/metastatic nasopharyngeal carcinoma, ovarian cancer, ...